## Abstract ## BACKGROUND The effects of multimodality treatment on the survival of patients with esophageal carcinoma are unclear. The authors performed a prospective, Phase II study to assess the longβterm results of chemotherapy plus radiotherapy (RT) on patients with esophageal squamous cell c
β¦ LIBER β¦
Appraisal of Ten-Year Survival following Esophagectomy for Carcinoma of the Esophagus with Emphasis on Quality of Life
β Scribed by Masamichi Baba; Takashi Aikou; Shoji Natsugoe; Chikara Kusano; Mario Shimada; Shigeto Kimura; Toshitaka Fukumoto
- Publisher
- Springer
- Year
- 1997
- Tongue
- English
- Weight
- 317 KB
- Volume
- 21
- Category
- Article
- ISSN
- 0364-2313
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Ten-year survival with chemotherapy and
β
Paolo Bidoli; Emilio Bajetta; Simonetta C. Stani; Daniela De Candis; Armando San
π
Article
π
2002
π
John Wiley and Sons
π
English
β 92 KB
π 1 views
Ten year experience with pre-operative r
β
Richard D. Marks Jr.; Richard H. Fitzgerald; Terence N. Moore; Keene M. Wallace
π
Article
π
1980
π
Elsevier Science
π
English
β 209 KB
Effect of traditional Chinese medicine o
β
Lu Ping; Liang Qiu-dong; Li Rong; Niu Hong-rui; Kou Xiao-ge; Xi Hong-jun
π
Article
π
2006
π
Chinese Association of Traditional and Western Med
π
English
β 406 KB
Follicular neoplasms of the thyroid. A s
β
Harry L. Evans
π
Article
π
1984
π
John Wiley and Sons
π
English
β 763 KB
Effects of home-based exercise program o
β
AltΔ±nay GΓΆksel Karatepe; Rezzan GΓΌnaydin; GΓΌl TΓΌrkmen; Taciser Kaya
π
Article
π
2009
π
Springer
π
English
β 228 KB
The impact of age on toxicity, response
β
Thomas A. Hensing; Amy H. Peterman; Michael J. Schell; Ji-Hyun Lee; Mark A. Soci
π
Article
π
2003
π
John Wiley and Sons
π
English
β 109 KB
π 2 views
## Abstract ## BACKGROUND The optimal treatment strategy for elderly patients with advanced nonsmall cell lung carcinoma has not been defined to date. The authors performed a retrospective analysis of a Phase III trial that treated patients who had Stage IIIB or IV nonsmall cell lung carcinoma wit